Regulatory Actions

Cameron Macdonald Appointed Managing Director of Controlled Therapeutics (Scotland) Limited

Published in Medical Letter on the CDC and FDA, April 22nd, 2007

Cytokine PharmaSciences, Inc. (CPSI) announced that Cameron Macdonald, Ph.D. will become the Managing Director of the Company's wholly owned operating subsidiary, Controlled Therapeutics (Scotland) Limited (CTS). Dr. Macdonald will also be named a Vice President of CPSI.

Dr. Macdonald earned a degree in biochemistry with first class honors from Strathclyde University. He later received his doctorate from the Department of Materia Medica at the University of Glasgow. Dr. Macdonald has had a distinguished career in the pharmaceutical industry in positions such as Executive Director, Marketing and Sales, for Hoechst-Roussel and Chief Executive Officer of PanTherix. Most...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-04-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry